Skip to content

Improvement of cognitive function by ingestion of Phosphatidylserine containing supplement

Improvement of cognitive function by ingestion of Phosphatidylserine containing supplement - Improvement of cognitive function by Phosphatidylserine

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000036999
Enrollment
40
Registered
2020-06-05
Start date
2019-06-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Take 3 tablets of Phosphatidylserine-containing supplement daily for 6 weeks Take 3 placebo tablets daily for 6 weeks

Sponsors

Faculty of Humanity-Oriented Science and Engineering, Kindai University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)persons who is 60 years old or older (2)persons who is generally judged as healthy (3)persons who can give voluntary written consent to participate in the present trial

Exclusion criteria

Exclusion criteria: (1)persons who have any dietary supplements, quasi drugs or medicines which cause same or similar efficacy with the effect evaluated in this study (2)persons who have changed their habitats to take supplements within past 4 weeks. (3)persons who work in night shift or in day and night shift (4)persons who have been treated their illness or prevention in a clinic at their informed consent (5)persons with their medical histories as follows: serious diseases of sugar metabolism, lipid metabolism, hepatic function, renal function, heart, circulatory, respiratory, endocrine system, immune system, or mental illness of the nervous system (6)persons with the medical histories of alcoholism or drug dependence (7)persons who might be developed allergic reaction to foods. (8)persons who are pregnant, breast-feeding, or hope to be pregnant during the study period (9)persons who had always participated in or will participate in any other clinical trial (to use foods/medicine/quasi medicine/medical device) (10)persons who will not be judged suitable to the participants by the investigator

Design outcomes

Primary

MeasureTime frame
Evaluate cognitive function using Mini Mental State Examination (MMSE)

Secondary

MeasureTime frame
Standard verbal paired-associate learning test, Benton visual retention test

Countries

Japan

Contacts

Public ContactOhnuki Koichiro

Faculty of Humanity-Oriented Science and Engineering, Kindai University Food Functional Science Laboratory

ohnuki@fuk.kindai.ac.jp0948-22-5655

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026